| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AKRO | Common Stock | Options Exercise | $444 | +722 | +0.4% | $0.62* | 183K | Dec 27, 2022 | Direct | F1 |
| transaction | AKRO | Common Stock | Options Exercise | $74.9K | +11.8K | +6.43% | $6.36* | 195K | Dec 27, 2022 | Direct | F1 |
| transaction | AKRO | Common Stock | Sale | -$620K | -12.5K | -6.41% | $49.57 | 182K | Dec 27, 2022 | Direct | F1, F2 |
| holding | AKRO | Common Stock | 20K | Dec 27, 2022 | By EA Irrevocable Trust | F3 | |||||
| holding | AKRO | Common Stock | 20K | Dec 27, 2022 | By CM Irrevocable Trust | F3 | |||||
| holding | AKRO | Common Stock | 20K | Dec 27, 2022 | By JL Irrevocable Trust | F3 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AKRO | Employee Stock Option (Right to Buy) | Options Exercise | $0 | -11.8K | -19.55% | $0.00 | 48.5K | Dec 27, 2022 | Common Stock | 11.8K | $6.36 | Direct | F1, F4 |
| transaction | AKRO | Employee Stock Option (Right to Buy) | Options Exercise | $0 | -722 | -0.78% | $0.00 | 92.1K | Dec 27, 2022 | Common Stock | 722 | $0.62 | Direct | F1, F5 |
| Id | Content |
|---|---|
| F1 | The reported transaction was effected pursuant to a Rule 10b5-1 trading plan dated June 9, 2021, previously adopted by the reporting person. |
| F2 | The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $49.50 to $49.75, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4. |
| F3 | These shares are held in irrevocable trusts for the benefit of the reporting person's children. The reporting person's spouse is trustee of the trusts. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. |
| F4 | This option shall vest and become exercisable in 48 equal monthly installments, commencing on January 1, 2019. |
| F5 | The options are vested and currently exercisable. |